Non-Insulin Therapies for Diabetes Market Report

Global Non-Insulin Therapies for Diabetes Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Mar 18, 2021
  • PAGES：230
  • REPORT CODE：GMM629415
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Non-Insulin Therapies for Diabetes is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Non-Insulin Therapies for Diabetes market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Non-Insulin Therapies for Diabetes industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Non-Insulin Therapies for Diabetes Market Segmentations:

    By Players:

    • Alkem Labs

    • Sumitomo Dainippon Pharma

    • Uni-Bio Science Group

    • Merck

    • GSK

    • Eurofarma

    • 3SBio

    • Luye Pharma Group

    • Novo Nordisk

    • Bristol-Myers Squibb

    • Servier

    • AstraZeneca

    • Novartis AG

    • Takeda

    • Geropharm

    • Dong-A Pharmaceutical

    • Emisphere

    • Eli Lilly

    • Pfizer

    • Jiangsu Hengrui Medicine

    By Types:

    • Alpha-glucosidase Inhibitors

    • Amylin Agonists

    • Biguanides

    • Dipeptidyl Peptidase-4 (DPP4) Inhibitors

    • Glinides / Meglitinides

    • GLP-1 Analogs / GLP-1 Agonists

    • Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

    • Sulfonylureas

    • Thiazolidinediones

    • Others

    By End-User:

    • Hospital Pharmacy

    • Retail Pharmacies

    • Online Pharmacy

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Non-Insulin Therapies for Diabetes Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Alpha-glucosidase Inhibitors from 2014 to 2026

      • 1.3.2 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Amylin Agonists from 2014 to 2026

      • 1.3.3 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Biguanides from 2014 to 2026

      • 1.3.4 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Dipeptidyl Peptidase-4 (DPP4) Inhibitors from 2014 to 2026

      • 1.3.5 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Glinides / Meglitinides from 2014 to 2026

      • 1.3.6 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of GLP-1 Analogs / GLP-1 Agonists from 2014 to 2026

      • 1.3.7 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors from 2014 to 2026

      • 1.3.8 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Sulfonylureas from 2014 to 2026

      • 1.3.9 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Thiazolidinediones from 2014 to 2026

      • 1.3.10 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026

      • 1.4.2 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

      • 1.4.3 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Online Pharmacy from 2014 to 2026

      • 1.4.4 Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Non-Insulin Therapies for Diabetes Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Non-Insulin Therapies for Diabetes Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Non-Insulin Therapies for Diabetes by Major Types

      • 3.4.1 Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Alpha-glucosidase Inhibitors

      • 3.4.2 Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Amylin Agonists

      • 3.4.3 Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Biguanides

      • 3.4.4 Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Dipeptidyl Peptidase-4 (DPP4) Inhibitors

      • 3.4.5 Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Glinides / Meglitinides

      • 3.4.6 Non-Insulin Therapies for Diabetes Market Size and Growth Rate of GLP-1 Analogs / GLP-1 Agonists

      • 3.4.7 Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

      • 3.4.8 Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Sulfonylureas

      • 3.4.9 Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Thiazolidinediones

      • 3.4.10 Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Others

    4 Segmentation of Non-Insulin Therapies for Diabetes Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Non-Insulin Therapies for Diabetes by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Non-Insulin Therapies for Diabetes in Hospital Pharmacy

      • 4.4.2 Market Size and Growth Rate of Non-Insulin Therapies for Diabetes in Retail Pharmacies

      • 4.4.3 Market Size and Growth Rate of Non-Insulin Therapies for Diabetes in Online Pharmacy

      • 4.4.4 Market Size and Growth Rate of Non-Insulin Therapies for Diabetes in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Non-Insulin Therapies for Diabetes Production Analysis by Major Regions

    • 5.2 Global Non-Insulin Therapies for Diabetes Consumption Analysis by Major Regions

    • 5.3 Global Non-Insulin Therapies for Diabetes Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Non-Insulin Therapies for Diabetes Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Non-Insulin Therapies for Diabetes Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Non-Insulin Therapies for Diabetes Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Production, Import, Consumption and Export Analysis

    6 Product Commodity of Non-Insulin Therapies for Diabetes Market in Major Countries

    • 6.1 Top 5 Export Countries in Non-Insulin Therapies for Diabetes market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Non-Insulin Therapies for Diabetes market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Non-Insulin Therapies for Diabetes market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Non-Insulin Therapies for Diabetes market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Non-Insulin Therapies for Diabetes market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Non-Insulin Therapies for Diabetes market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Non-Insulin Therapies for Diabetes Landscape Analysis

    • 7.1 North America Non-Insulin Therapies for Diabetes Landscape Analysis by Major Types

    • 7.2 North America Non-Insulin Therapies for Diabetes Landscape Analysis by Major End-Users

    • 7.3 North America Non-Insulin Therapies for Diabetes Landscape Analysis by Major Countries

      • 7.3.1 United States Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 7.3.2 Canada Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 7.3.3 Mexico Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

    8 Europe Non-Insulin Therapies for Diabetes Landscape Analysis

    • 8.1 Europe Non-Insulin Therapies for Diabetes Landscape Analysis by Major Types

    • 8.2 Europe Non-Insulin Therapies for Diabetes Landscape Analysis by Major End-Users

    • 8.3 Europe Non-Insulin Therapies for Diabetes Landscape Analysis by Major Countries

      • 8.3.1 Germany Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 8.3.2 UK Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 8.3.3 France Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 8.3.4 Italy Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 8.3.6 Spain Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 8.3.7 Belgium Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 8.3.8 Poland Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 8.3.9 Russia Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 8.3.10 Turkey Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

    9 Asia Pacific Non-Insulin Therapies for Diabetes Landscape Analysis

    • 9.1 Asia Pacific Non-Insulin Therapies for Diabetes Landscape Analysis by Major Types

    • 9.2 Asia Pacific Non-Insulin Therapies for Diabetes Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Non-Insulin Therapies for Diabetes Landscape Analysis by Major Countries

      • 9.3.1 China Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 9.3.2 Japan Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 9.3.4 India Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 9.3.6 South Korea Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 10.3.2 Brazil Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 10.3.3 Nigeria Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

      • 10.3.4 South Africa Non-Insulin Therapies for Diabetes Market Volume and Growth Rate 

      • 10.3.5 Argentina Non-Insulin Therapies for Diabetes Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Alkem Labs

      • 11.1.1 Alkem Labs Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sumitomo Dainippon Pharma

      • 11.2.1 Sumitomo Dainippon Pharma Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Uni-Bio Science Group

      • 11.3.1 Uni-Bio Science Group Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Merck

      • 11.4.1 Merck Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 GSK

      • 11.5.1 GSK Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Eurofarma

      • 11.6.1 Eurofarma Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 3SBio

      • 11.7.1 3SBio Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Luye Pharma Group

      • 11.8.1 Luye Pharma Group Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Novo Nordisk

      • 11.9.1 Novo Nordisk Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Bristol-Myers Squibb

      • 11.10.1 Bristol-Myers Squibb Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Servier

      • 11.11.1 Servier Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 AstraZeneca

      • 11.12.1 AstraZeneca Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Novartis AG

      • 11.13.1 Novartis AG Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Takeda

      • 11.14.1 Takeda Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Geropharm

      • 11.15.1 Geropharm Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Dong-A Pharmaceutical

      • 11.16.1 Dong-A Pharmaceutical Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Emisphere

      • 11.17.1 Emisphere Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Eli Lilly

      • 11.18.1 Eli Lilly Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Pfizer

      • 11.19.1 Pfizer Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Jiangsu Hengrui Medicine

      • 11.20.1 Jiangsu Hengrui Medicine Company Profile and Recent Development

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 116 Figures and 207 Tables)

    • Figure Product Picture

    • Figure Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Alpha-glucosidase Inhibitors from 2014 to 2026

    • Figure Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Amylin Agonists from 2014 to 2026

    • Figure Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Biguanides from 2014 to 2026

    • Figure Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Dipeptidyl Peptidase-4 (DPP4) Inhibitors from 2014 to 2026

    • Figure Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Glinides / Meglitinides from 2014 to 2026

    • Figure Non-Insulin Therapies for Diabetes Market Size and Growth Rate of GLP-1 Analogs / GLP-1 Agonists from 2014 to 2026

    • Figure Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors from 2014 to 2026

    • Figure Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Sulfonylureas from 2014 to 2026

    • Figure Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Thiazolidinediones from 2014 to 2026

    • Figure Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026

    • Figure Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Online Pharmacy from 2014 to 2026

    • Figure Global Non-Insulin Therapies for Diabetes Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Non-Insulin Therapies for Diabetes Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Non-Insulin Therapies for Diabetes Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Non-Insulin Therapies for Diabetes

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Non-Insulin Therapies for Diabetes by Different Types from 2014 to 2026

    • Table Consumption Share of Non-Insulin Therapies for Diabetes by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Alpha-glucosidase Inhibitors

    • Figure Market Size and Growth Rate of Amylin Agonists

    • Figure Market Size and Growth Rate of Biguanides

    • Figure Market Size and Growth Rate of Dipeptidyl Peptidase-4 (DPP4) Inhibitors

    • Figure Market Size and Growth Rate of Glinides / Meglitinides

    • Figure Market Size and Growth Rate of GLP-1 Analogs / GLP-1 Agonists

    • Figure Market Size and Growth Rate of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

    • Figure Market Size and Growth Rate of Sulfonylureas

    • Figure Market Size and Growth Rate of Thiazolidinediones

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Non-Insulin Therapies for Diabetes by Different End-Users from 2014 to 2026

    • Table Consumption Share of Non-Insulin Therapies for Diabetes by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacy

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacy

    • Figure Market Size and Growth Rate of Others

    • Table Global Non-Insulin Therapies for Diabetes Production by Major Regions

    • Table Global Non-Insulin Therapies for Diabetes Production Share by Major Regions

    • Figure Global Non-Insulin Therapies for Diabetes Production Share by Major Regions in 2014

    • Figure Global Non-Insulin Therapies for Diabetes Production Share by Major Regions in 2018

    • Figure Global Non-Insulin Therapies for Diabetes Production Share by Major Regions in 2026

    • Table Global Non-Insulin Therapies for Diabetes Consumption by Major Regions

    • Table Global Non-Insulin Therapies for Diabetes Consumption Share by Major Regions

    • Figure Global Non-Insulin Therapies for Diabetes Consumption Share by Major Regions in 2014

    • Figure Global Non-Insulin Therapies for Diabetes Consumption Share by Major Regions in 2018

    • Figure Global Non-Insulin Therapies for Diabetes Consumption Share by Major Regions in 2026

    • Table North America Non-Insulin Therapies for Diabetes Production, Import, Consumption and Export Analysis

    • Table Europe Non-Insulin Therapies for Diabetes Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Non-Insulin Therapies for Diabetes Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Non-Insulin Therapies for Diabetes market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Non-Insulin Therapies for Diabetes market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Non-Insulin Therapies for Diabetes market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Non-Insulin Therapies for Diabetes market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Non-Insulin Therapies for Diabetes Consumption by Types from 2014 to 2026

    • Table North America Non-Insulin Therapies for Diabetes Consumption Share by Types from 2014 to 2026

    • Figure North America Non-Insulin Therapies for Diabetes Consumption Share by Types in 2014

    • Figure North America Non-Insulin Therapies for Diabetes Consumption Share by Types in 2018

    • Figure North America Non-Insulin Therapies for Diabetes Consumption Share by Types in 2026

    • Table North America Non-Insulin Therapies for Diabetes Consumption by End-Users from 2014 to 2026

    • Table North America Non-Insulin Therapies for Diabetes Consumption Share by End-Users from 2014 to 2026

    • Figure North America Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2014

    • Figure North America Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2018

    • Figure North America Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2026

    • Table North America Non-Insulin Therapies for Diabetes Consumption by Major Countries from 2014 to 2026

    • Table North America Non-Insulin Therapies for Diabetes Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2014

    • Figure North America Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2018

    • Figure North America Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2026

    • Figure United States Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Non-Insulin Therapies for Diabetes Consumption by Types from 2014 to 2026

    • Table Europe Non-Insulin Therapies for Diabetes Consumption Share by Types from 2014 to 2026

    • Figure Europe Non-Insulin Therapies for Diabetes Consumption Share by Types in 2014

    • Figure Europe Non-Insulin Therapies for Diabetes Consumption Share by Types in 2018

    • Figure Europe Non-Insulin Therapies for Diabetes Consumption Share by Types in 2026

    • Table Europe Non-Insulin Therapies for Diabetes Consumption by End-Users from 2014 to 2026

    • Table Europe Non-Insulin Therapies for Diabetes Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2014

    • Figure Europe Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2018

    • Figure Europe Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2026

    • Table Europe Non-Insulin Therapies for Diabetes Consumption by Major Countries from 2014 to 2026

    • Table Europe Non-Insulin Therapies for Diabetes Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2014

    • Figure Europe Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2018

    • Figure Europe Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2026

    • Figure Germany Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure France Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Non-Insulin Therapies for Diabetes Consumption by Types from 2014 to 2026

    • Table Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by Types in 2014

    • Figure Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by Types in 2018

    • Figure Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by Types in 2026

    • Table Asia Pacific Non-Insulin Therapies for Diabetes Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2014

    • Figure Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2018

    • Figure Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2026

    • Table Asia Pacific Non-Insulin Therapies for Diabetes Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2026

    • Figure China Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandNon-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure India Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Non-Insulin Therapies for Diabetes Consumption Share by Major Countries in 2026

    • Figure GCC Countries Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Non-Insulin Therapies for Diabetes Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Alkem Labs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alkem Labs

    • Figure Sales and Growth Rate Analysis of Alkem Labs

    • Figure Revenue and Market Share Analysis of Alkem Labs

    • Table Product and Service Introduction of Alkem Labs

    • Table Company Profile and Development Status of Sumitomo Dainippon Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sumitomo Dainippon Pharma

    • Figure Sales and Growth Rate Analysis of Sumitomo Dainippon Pharma

    • Figure Revenue and Market Share Analysis of Sumitomo Dainippon Pharma

    • Table Product and Service Introduction of Sumitomo Dainippon Pharma

    • Table Company Profile and Development Status of Uni-Bio Science Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Uni-Bio Science Group

    • Figure Sales and Growth Rate Analysis of Uni-Bio Science Group

    • Figure Revenue and Market Share Analysis of Uni-Bio Science Group

    • Table Product and Service Introduction of Uni-Bio Science Group

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Eurofarma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eurofarma

    • Figure Sales and Growth Rate Analysis of Eurofarma

    • Figure Revenue and Market Share Analysis of Eurofarma

    • Table Product and Service Introduction of Eurofarma

    • Table Company Profile and Development Status of 3SBio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3SBio

    • Figure Sales and Growth Rate Analysis of 3SBio

    • Figure Revenue and Market Share Analysis of 3SBio

    • Table Product and Service Introduction of 3SBio

    • Table Company Profile and Development Status of Luye Pharma Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Luye Pharma Group

    • Figure Sales and Growth Rate Analysis of Luye Pharma Group

    • Figure Revenue and Market Share Analysis of Luye Pharma Group

    • Table Product and Service Introduction of Luye Pharma Group

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Servier

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Servier

    • Figure Sales and Growth Rate Analysis of Servier

    • Figure Revenue and Market Share Analysis of Servier

    • Table Product and Service Introduction of Servier

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Takeda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

    • Figure Sales and Growth Rate Analysis of Takeda

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Product and Service Introduction of Takeda

    • Table Company Profile and Development Status of Geropharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Geropharm

    • Figure Sales and Growth Rate Analysis of Geropharm

    • Figure Revenue and Market Share Analysis of Geropharm

    • Table Product and Service Introduction of Geropharm

    • Table Company Profile and Development Status of Dong-A Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dong-A Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Dong-A Pharmaceutical

    • Figure Revenue and Market Share Analysis of Dong-A Pharmaceutical

    • Table Product and Service Introduction of Dong-A Pharmaceutical

    • Table Company Profile and Development Status of Emisphere

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emisphere

    • Figure Sales and Growth Rate Analysis of Emisphere

    • Figure Revenue and Market Share Analysis of Emisphere

    • Table Product and Service Introduction of Emisphere

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Jiangsu Hengrui Medicine

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangsu Hengrui Medicine

    • Figure Sales and Growth Rate Analysis of Jiangsu Hengrui Medicine

    • Figure Revenue and Market Share Analysis of Jiangsu Hengrui Medicine

    • Table Product and Service Introduction of Jiangsu Hengrui Medicine


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US